Metformin Hydrochloride Studies


Metformin HydrochlorideMetformin Hydrochloride is one of the most recommended medicines for the treatment of patients suffering from biguanide or type 2 Diabetes. According to recent studies, Metformin Hydrochloride reduces the LDL and triglyceride levels in the blood and hence it is one of the best medicines for diabetic patients who are also suffering with obesity. Studies are being performed to establish Metformin Hydrochloride as an efficient solution for the issues of patients suffering from gestational diabetes.

Importance of Metformin Hydrochloride as the first choice for Diabetic patients

This oral anti-diabetic drug has established itself as one of the major anti-diabetic drug throughout the world. In the year 2009, 42 million prescriptions were made for U.S patients suffering from type 2 Diabetes. Some researches reveal that during the study period of 10 years, patients who used Metformin, improved against the diabetes complications and mortality rate by 30% when compared with the results in patients who were treated with sulfonylureas and insulin. The same results for the patients treated with Metformin were better by 40% when compared with the patients who were prescribed to maintain dietary control alone.

Metformin HCL is usually the first drug of choice for most patients suffering from diabetes and obesity. This is primarily because Metformin causes very little to no weight gain at all, and lessens the chances of hpoglycaemic attacks in the patient. This differs greatly from sulphonylureas and insulin which cause significant weight gain and risks of hypoglycaemic attacks.

Further uses of Metformin Hydrochloride

With the recent success of experiments that indicates that Metformin can be efficient to alleviate issues related with premature puberty, non-alcoholic fatty liver disease and polycystic ovary syndrome, Metformin Hydrochloride is gaining popularity as a common drug with the least side effects and efficient results.

During a study conducted on mice, scientists established that Metformin can also play an effective role on controlling tobacco-induced lung cancer. In September 2010, Cancer Prevention Research published a report mentioning that Metformin Hydrochloride was found effective to reduce the number of tumor in mice by 73%. The tumors in mice were caused with the effect of common carcinogen found in tobacco.

Thus, apart from being a highly recommended drug for type 2 Diabetic patients suffering from obesity, Metformin HCL may soon be used as a drug to cure tobacco-induced lung cancer.

LGM Pharma is a US based supplier of the API (Active Pharmaceutical Ingredient) Metformin HCL for research and development purposes.  Inquire about Metformin Hydrochloride CAS# 1115-70-4 prices, availability, delivery, purity and more.

*Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

  • Share: